Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
NCT ID: NCT03921294
Description: Standard definitions
Frequency Threshold: 0
Time Frame: Every 3 months, for the 2 years and 10 months of the patient's study participation duration.
Study: NCT03921294
Study Brief: HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Single Arm Patients with hemophilic pseudotumor will be treated with prophylactic emicizumab and assessed for improvement. Emicizumab: bispecific monoclonal antibody binding to activated Factor IX and Factor X 0 None 0 1 1 1 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper respiratory infection SYSTEMATIC_ASSESSMENT General disorders SNOMED CT View
Fall with injurty SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders SNOMED CT View
Malaria infection SYSTEMATIC_ASSESSMENT Infections and infestations SNOMED CT View